S1PR1 and ovarian carcinoma: To investigate whether S1PR1 can affect ovarian cancer chemotherapy resistance through senescence, we first detected its expression in tissues from chemoresistant patients (CDDP-resistant) and chemosensitive patients (CDDP-sensitive).